MMS is a 28% sodium chlorite solution, which is equivalent to industrial-strength bleach. When taken as directed it could cause severe nausea, vomiting and diarrhoea, potentially leading to dehydration and reduced blood pressure. If the solution is diluted less than instructed, it could cause damage to the gut and red blood cells, potentially resulting in respiratory failure.
Good Thinking Society report on Trading Standards action about a conference held by the Texas Genesis II Church of Health and Healing, which promotes MMS, in Surrey in June.
This so-called “miracle mineral solution” appears to target vulnerable people and those suffering serious illnesses who are asked to pay large sums of money for a product which not only doesn’t work but could be dangerous.
The manufacturer, VIP Electronic Cigarette, says this is the first time the act of using an electronic cigarette – or vaping – has been shown on television. It appeared in an ad break in Grantchester, ITV1’s smoke-wreathed drama about a 1950s country vicar who falls over corpses in between lighting cigarettes. Continue reading →
Legal, decent, honest and truthful. It doesn’t sound too much to ask, but many traders
continue to use misleading advertising claims on their websites – and the list is dominated by health products.
If the UK Advertising Standards Authority (ASA) decides that an online ad does not comply with the UK Advertising Code, it will make repeated requests for the dubious claim to be
amended: if traders still fail to comply, then details of the claim and the ASA decision are published. Looking down the list, it is dominated by health products, including something I misread as psychic dentistry. Continue reading →
To assess the evidence, you need to know it is there.
Properly conducted clinical trials provide the best evidence for whether drugs work and are safe. But about half have never been published, and trials with positive results – where the drug concerned is shown to be safe and effective – are more likely to be published than negative ones. Patients can be harmed – for example if a treatment found to be harmful in an invisible trial is then given to patients in a new one – or medicines used ineffectively or wastefully, as a result. Researchers can’t plan research properly because they don’t know what has gone before. The problems with this situation have been well documented for years, but things may now be going to change.